Botulinum toxin therapy: reduction of injection site pain by pH normalisation
Authors:
- 22 March 2016
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 123 (5) , 527-531
Abstract
Botulinum toxin (BT) is injected intramuscularily and may produce injection site pain (ISP). We wanted to explore whether the pH value of the reconstituted BT drug contributes to ISP and, if so, what strategies can be applied to reduce it. In part 1 of the study, pH values of different reconstitution solutions and of major BT drugs reconstituted with different reconstitution solutions were assessed. In part 2, the effects of reconstitution with normal saline (NS) and Ringer acetate (RA) were compared intraindividually and in a double blind fashion in 34 patients with blepharospasm. pH values of reconstitution solutions were 5.52 ± 0.02 for NS, 6.98 for RA, 6.31 for Ringer lactate, 6.56 for electrolyte and 5.31 for bacteriostatic solution. pH values for NS-reconstitution were 6.09 ± 0.20 for Botox®, 5.95 ± 0.24 for Dysport® and 5.81 ± 0.18 for Xeomin®. pH values for RA-reconstitution were 6.95 ± 0.03 for Botox®, 7.01 ± 0.02 for Dysport® and 6.87 ± 0.06 for Xeomin®. By using RA instead of NS the pH could be increased by 0.86 for Botox®, by 1.06 for Dysport® and by 1.06 for Xeomin®. 47 % of the patients experienced less ISP when Botox®-RA was given rather than Botox®-NS, 76 % when Xeomin®-RA was given rather than Xeomin®-NS. None of the patients reported a difference in efficacy between NS- and RA-reconstitution. Despite previous reports, reconstituted BT type A drugs show acidic pH values. Normalising these pH values by use of RA instead of NS reduces ISP considerably without sacrificing clincial efficacy.Keywords
Funding Information
- Departmental funding
This publication has 8 references indexed in Scilit:
- Pain Difference Associated with Injection of AbobotulinumtoxinA Reconstituted with Preserved Saline and Preservative-Free Saline: A Prospective, Randomized, Side-by-Side, Double-Blind StudyDermatologic Surgery, 2012
- Manual of Botulinum Toxin Therapy2009
- Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind studyBritish Journal of Dermatology, 2007
- Evaluating Effects of Preservative-Containing Saline Solution on Pain Perception During Botulinum Toxin Type-A Injections at Different Locations: A Prospective, Single-Blinded, Randomized Controlled TrialAesthetic Plastic Surgery, 2005
- Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: A double-blind, randomized controlled trialJournal of the American Academy of Dermatology, 2003
- Botulinum toxin type B for treatment of axillar hyperhidrosisJournal of Neurology, 2002
- Anesthesia with EMLA® Cream for Botulinum A Toxin Injection into EyelidsOphthalmologica, 2002
- Pain Associated With Injection of Botulinum A Exotoxin Reconstituted Using Isotonic Sodium Chloride With and Without PreservativeArchives of Dermatology, 2002